FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1584922481> ?p ?o ?g. }

• W1584922481 endingPage "114" @default.
• W1584922481 startingPage "105" @default.
• W1584922481 abstract "Blood uric acid levels and purine metabolism are affected in many ways after bone marrow transplantation (BMT). Although BMT is usually performed when patients have a low residual disease burden, a proportion of them are still at risk of tumor lysis syndrome, even with limited disease or after nonmyeloablative conditioning regimens; moreover, an alteration in uric acid turnover can also be observed in patients with persistently normal uric acid blood levels. Apart from this obvious complication, multiple physiopathological events occurring after transplantation may derange uric acid homeostasis. Although there is only indirect evidence (derived from obstetric eclampsia and experimental gout arthritis), a transplant-related increase in cytokine production (particularly TNF, IL-1 and IL-6) may activate xanthine oxidase which, in turn, may be responsible for a further cytokine bout: deranged cytokine homeostasis is involved in the pathogenesis of some of the main acute post-BMT complications, such as hepatic veno-occlusive disease (VOD) and acute graft-versus-host disease (aGVHD). Hyperuricemia is also a well-known side effect of cyclosporine A, the reference drug for the prevention of post-BMT GVHD, which may affect uric acid turnover by reducing glomerular filtration and/or affecting tubular handling; the available evidence favors the former explanation. Hyperuricemia is found in long-term transplanted patients as part of a metabolic pattern reminiscent of the so-called 'X' or 'metabolic'syndrome related to insulin resistance: there is still no precise interpretation of this post-transplant complication nor any definite data concerning its real incidence and outcome. Hyperuricemia is frequently regarded as a marginal finding in the context of X syndrome, but it is pathogenetically linked to the other component of the syndrome and has proved to be autonomously responsible for tissue and vessel damage. Finally, BMT is a possible therapeutic strategy for some inherited forms of hyperuricemia, particularly Lesch- Nyhan disease, although there is still some perplexity concerning the possibility of preventing the development of neurological impairment." @default.
• W1584922481 created "2016-06-24" @default.
• W1584922481 creator A5013280983 @default.
• W1584922481 creator A5078106084 @default.
• W1584922481 date "2004-01-01" @default.
• W1584922481 modified "2023-10-16" @default.
• W1584922481 title "Hyperuricemia and Bone Marrow Transplantation" @default.
• W1584922481 cites W1221138243 @default.
• W1584922481 cites W1273018688 @default.
• W1584922481 cites W150322466 @default.
• W1584922481 cites W1782469574 @default.
• W1584922481 cites W179119018 @default.
• W1584922481 cites W1916439091 @default.
• W1584922481 cites W1969795510 @default.
• W1584922481 cites W1972643273 @default.
• W1584922481 cites W1976137373 @default.
• W1584922481 cites W1978007486 @default.
• W1584922481 cites W1987547326 @default.
• W1584922481 cites W1995333615 @default.
• W1584922481 cites W2004836379 @default.
• W1584922481 cites W2008506750 @default.
• W1584922481 cites W2010799434 @default.
• W1584922481 cites W2013857760 @default.
• W1584922481 cites W2020806415 @default.
• W1584922481 cites W2021890186 @default.
• W1584922481 cites W2025209028 @default.
• W1584922481 cites W2026959361 @default.
• W1584922481 cites W2028313957 @default.
• W1584922481 cites W2039117216 @default.
• W1584922481 cites W2055847751 @default.
• W1584922481 cites W2056140215 @default.
• W1584922481 cites W2057215390 @default.
• W1584922481 cites W2063035362 @default.
• W1584922481 cites W2070593909 @default.
• W1584922481 cites W2078245616 @default.
• W1584922481 cites W2084619378 @default.
• W1584922481 cites W2086415014 @default.
• W1584922481 cites W2089850042 @default.
• W1584922481 cites W2097688878 @default.
• W1584922481 cites W2109469605 @default.
• W1584922481 cites W2120809415 @default.
• W1584922481 cites W2137731448 @default.
• W1584922481 cites W2137971591 @default.
• W1584922481 cites W2139903790 @default.
• W1584922481 cites W2142373144 @default.
• W1584922481 cites W2151834039 @default.
• W1584922481 cites W2168638212 @default.
• W1584922481 cites W2169848862 @default.
• W1584922481 cites W2232997227 @default.
• W1584922481 cites W239159500 @default.
• W1584922481 cites W2401316200 @default.
• W1584922481 cites W2401797098 @default.
• W1584922481 cites W2403172023 @default.
• W1584922481 cites W2412124747 @default.
• W1584922481 cites W2415573929 @default.
• W1584922481 cites W2417489194 @default.
• W1584922481 cites W2425481931 @default.
• W1584922481 cites W2430382737 @default.
• W1584922481 cites W2467685314 @default.
• W1584922481 cites W2469387726 @default.
• W1584922481 cites W42721487 @default.
• W1584922481 cites W67604591 @default.
• W1584922481 cites W83722994 @default.
• W1584922481 doi "https://doi.org/10.1159/000082548" @default.
• W1584922481 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15604610" @default.
• W1584922481 hasPublicationYear "2004" @default.
• W1584922481 type Work @default.
• W1584922481 sameAs 1584922481 @default.
• W1584922481 citedByCount "5" @default.
• W1584922481 countsByYear W15849224812016 @default.
• W1584922481 countsByYear W15849224812021 @default.
• W1584922481 countsByYear W15849224812023 @default.
• W1584922481 crossrefType "book-chapter" @default.
• W1584922481 hasAuthorship W1584922481A5013280983 @default.
• W1584922481 hasAuthorship W1584922481A5078106084 @default.
• W1584922481 hasConcept C126322002 @default.
• W1584922481 hasConcept C134018914 @default.
• W1584922481 hasConcept C181199279 @default.
• W1584922481 hasConcept C185592680 @default.
• W1584922481 hasConcept C203014093 @default.
• W1584922481 hasConcept C2778102346 @default.
• W1584922481 hasConcept C2779721657 @default.
• W1584922481 hasConcept C2779881121 @default.
• W1584922481 hasConcept C2780261098 @default.
• W1584922481 hasConcept C2911091166 @default.
• W1584922481 hasConcept C55493867 @default.
• W1584922481 hasConcept C71924100 @default.
• W1584922481 hasConcept C90924648 @default.
• W1584922481 hasConceptScore W1584922481C126322002 @default.
• W1584922481 hasConceptScore W1584922481C134018914 @default.
• W1584922481 hasConceptScore W1584922481C181199279 @default.
• W1584922481 hasConceptScore W1584922481C185592680 @default.
• W1584922481 hasConceptScore W1584922481C203014093 @default.
• W1584922481 hasConceptScore W1584922481C2778102346 @default.
• W1584922481 hasConceptScore W1584922481C2779721657 @default.
• W1584922481 hasConceptScore W1584922481C2779881121 @default.
• W1584922481 hasConceptScore W1584922481C2780261098 @default.
• W1584922481 hasConceptScore W1584922481C2911091166 @default.

• next